PCN82 Budget Impact Analysis of Subcutaneous Daratumumab for the Treatment of Patients with Multiple Myeloma in Sweden

Dec 1, 2020, 00:00 AM
10.1016/j.jval.2020.08.219
https://www.valueinhealthjournal.com/article/S1098-3015(20)32475-X/fulltext
Section Title :
Section Order : 10170
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32475-X&doi=10.1016/j.jval.2020.08.219
HEOR Topics :
Tags :
Regions :